Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
1pm Plc
Financials
Group synergies coming through
By
Mark Thomas
12 Sep 2018
Redx Pharma
Life Sciences
Back to the clinic
06 Sep 2018
1pm Plc
Financials
Give credit where it is due
By
Mark Thomas
05 Sep 2018
Avacta Group plc
Life Sciences
Capital increase for further development
By
Dr Martin Hall
05 Sep 2018
Volta Finance
Financials
Delivering the structured finance opportunity
By
Mark Thomas
05 Sep 2018
The Monthly: September 2018
03 Sep 2018
Bionomics Ltd
Life Sciences
FY’18 – focus on PTSD drug development
By
Dr Martin Hall
03 Sep 2018
Advanced Oncotherapy
Life Sciences
Treatment planning system agreement
By
Dr Martin Hall
29 Aug 2018
Civitas Social Housing PLC
Property
Housing security
By
Mike Foster
24 Aug 2018
Oxford BioMedica
Life Sciences
Risk-sharing in cystic fibrosis gene-therapy
14 Aug 2018
Non-Standard Finance
Financials
1H’18 results: jam today, more tomorrow
By
Mark Thomas
09 Aug 2018
Prev
1
...
63
64
65
66
67
...
81
Next